Conference News
Conference News
- ADA 2023 COORDINATE-Diabetes: a 'Wake-Up Call' for Many Specialties
- ADA 2023 33% of Type 1 Diabetes Patients Insulin-Free With Stem Cells
- AHS 2023 Children of Color Get Less Testing, Diagnosis of Migraine
- ADA 2023 Survodutide Impresses in Phase 2 Weight-Loss Trial
- New ESH Hypertension Guidelines Aim for Simplified Message
- AHS 2023 Dual Treatment May Boost Efficacy in Chronic Migraine
- AHS 2023 REN Benefits for Migraine Begin as Early as 2 Weeks
- ILC 2023 Pegozafermin Improves Fibrosis in NASH in Phase 2b Study
- ADA 2023 Once-Weekly Basal Insulin Nears Market for Type 2 Diabetes
- AHS 2023 Can a Puff of Cool Air Up the Nose Stop Acute Migraine?
- ADA 2023 ADA: Screen All With Type 2 Diabetes for Fatty Liver Disease
- ADA 2023 Triple Agonist Retatrutide Hits New Weight-Loss Highs
- ILC 2023 Naltrexone Is Safe and Beneficial in AUD With Cirrhosis
- ENDO 2023 Early Time-Restricted Feeding Dampens Blood Glucose Peaks
- ILC 2023 Algorithm SAFE to Detect Liver Disease in General Population
- ENDO 2023 CGM Alarm Fatigue in Youth?
- ADA 2023 OASIS and PIONEER PLUS Support High-Dose Oral Semaglutide
- ADA 2023 Tackle Education and Mindset to Reduce Diabetes Distress
- ADA 2023 Kids With T2D Face Dire Complications as Young Adults
- ENDO 2023 Surgery, Radioactive Iodine for Hyperthyroidism Up Survival